Impact of Pulsed Field Ablation Dosing on Outcome After Pulmonary Vein Isolation Using a Pentaspline Ablation Catheter: A Prospective Comparison of 8 Versus 16 Applications
Journal of Cardiovascular Electrophysiology · 2026
DOI: 10.1111/jce.70266 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Katharina Ji-Mi Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, University Hospital Duesseldorf, Heinrich-Heine University Duesseldorf, D…. Hauptthemen laut MEDLINE: Pulmonary Veins, Atrial Fibrillation, Catheter Ablation, Cardiac Catheters. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pulsed field ablation (PFA) is a novel, non‐thermal ablation modality to achieve pulmonary vein isolation (PVI) for the treatment of atrial fibrillation (AF). For the pentaspline catheter, eight applications per pulmonary vein (PV) are considered standard, with four in basket configuration and four in flower configuration. The objective of the study is to investigate whether pentaspline PFA using 16 applications per PV is associated with an improved outcome compared with the standard procedure.
Methods
The prospective study included a total of 292 patients with AF. According to the number of applications per PV, patients were assigned to group PFA‐8 (8 applications per PV; 4x basket configuration, 4x flower configuration; n = 130) or group PFA‐16 (16 applications per PV; 6x basket, 10x flower; n = 162). The primary endpoint was freedom from atrial arrhythmia (AA), i.e. AF, atrial flutter, and atrial tachycardia, after a follow‐up period of 1 year, as assessed by Holter monitoring after 3 and 12 months, respectively.
Results
Freedom from AA was significantly higher in group PFA‐16 than in group PFA‐8 (73.9% vs. 62.3%; p < 0.05). Subgroup analysis showed greater effectiveness in the PFA‐16 group than in the PFA‐8 group (66.1% vs. 45.3%; p < 0.05) in patients with persistent AF, while freedom from AA was similar in both groups in patients with paroxysmal AF (78.8% in PFA‐16 vs. 75.7% in PFA‐8; p = ns). Serious adverse events were observed in 8 (2.7%) patients, with no differences between the two groups.
Conclusion
PVI using 16 PFA applications per PV may improve clinical outcome in patients with persistent AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, University Hospital Duesseldorf, Heinrich-Heine University Duesseldorf, Duesseldorf, Nordrhein-Westfalen, Germany.
- Cardiovascular Research Institute Duesseldorf, Medical Faculty, Heinrich-Heine University, Duesseldorf, Germany.
ORCID-Profile: Katharina Ji-Mi Yang, Alexandru Gabriel Bejinariu
Zitieren
APA
Yang, K. J., Spieker, M., Angendohr, S., Auf der Heiden, C., Glöckner, D., Sansone, R., Kelm, M., Bejinariu, A. G., & Rana, O. (2026). Impact of Pulsed Field Ablation Dosing on Outcome After Pulmonary Vein Isolation Using a Pentaspline Ablation Catheter: A Prospective Comparison of 8 Versus 16 Applications. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70266
Vancouver
Yang KJ, Spieker M, Angendohr S, Auf der Heiden C, Glöckner D, Sansone R, et al. Impact of Pulsed Field Ablation Dosing on Outcome After Pulmonary Vein Isolation Using a Pentaspline Ablation Catheter: A Prospective Comparison of 8 Versus 16 Applications. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70266
BibTeX
@article{Yang2026,
author = {Yang, Katharina Ji-Mi and Spieker, Maximilian and Angendohr, Stephan and Auf der Heiden, Carsten and Glöckner, David and Sansone, Roberto and Kelm, Malte and Bejinariu, Alexandru Gabriel and Rana, Obaida},
title = {Impact of Pulsed Field Ablation Dosing on Outcome After Pulmonary Vein Isolation Using a Pentaspline Ablation Catheter: A Prospective Comparison of 8 Versus 16 Applications},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
doi = {10.1111/jce.70266}
}
EUVIMED